What's your alternative?

    Biome Australia (ASX: BIO) develops, licenses, commercialises and markets innovative, evidence-based live biotherapeutics (probiotics) and complementary medicines that have been proven through double-blind, placebo-controlled human clinical trials. Incorporated in Australia in 2018, Biome distributes locally and abroad.

    Presenting at Small Caps, Big Ideas was CEO Blair Norfolk alongside Paul Hart from Canary Capital.

    Visit Biome's Investor Hub

    Disclaimer: companies appearing at this event have a commercial relationship with ausbiz.

    Meet our speakers

    Alvin Rogers Follow me on LinkedIn

    Director of Sales
    Big Corporation

    Lisa Smith Follow me on LinkedIn

    Creative Director
    Other Corporation

    James McGiven Follow me on LinkedIn

    Owner
    Small Agency

    ESSENTIAL ALTERNATIVES